HSIC vs ZTS · P/E 24, rev $6.83B vs P/E 25, rev $2.47B
Henry Schein Inc (HSIC) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the HSIC and ZTS stock pages for the full models.
Not investment advice.